Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | RO7293583 |
Trade Name | |
Synonyms | RO-7293583|RO 7293583 |
Drug Descriptions |
RO7293583 binds to both PRSS1 (TRP1) and CD3, potentially leads to the activation of CD3-expressing cytotoxic T lymphocytes (CTLs) and CTL-mediated killing of TYRP1-expressing tumor cells (NCI Drug Dictionary). |
DrugClasses | CD3 Antibody 99 |
CAS Registry Number | NA |
NCIT ID | C177437 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Obinutuzumab + RO7293583 + Tocilizumab | Obinutuzumab RO7293583 Tocilizumab | 0 | 1 |
RO7293583 | RO7293583 | 0 | 0 |
RO7293583 + Tocilizumab | RO7293583 Tocilizumab | 0 | 1 |